Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global 3D bioprinting market reached a value of US$ 869 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,260.1 Million by 2027, exhibiting a CAGR of 16.85% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

3D bioprinting refers to an additive manufacturing technique used for the development of precise anatomical tissues through the decomposition of cell-based bio-inks. 3D bioprinting involves various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing and inkjet deposition. The bio-inks are manufactured using living cells, biomaterials and active biomolecules to create 3D structures of tissues and organs. The printer deposits multiple layers of biomaterials to build complex bodily structures, such as bones, skin, vascular grafts, tracheal splints, heart tissues and cartilages. These printed structures are assembled and bonded using dissolvable gel or collagen scaffolds to support and mold the cells in the desired shape.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

3D Bioprinting Market Trends:

The increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) across the globe is one of the key factors driving the growth of the market. Moreover, the rising requirement for regenerative medicines, cancer therapeutics and stem cell solutions is providing a thrust to the market growth. 3D bioprinting is widely used for liver modeling and development of various bone, tissue and medical implants. In line with this, the increasing consciousness among the masses to minimize animal testing is also contributing to the market growth. Cosmetic manufacturers use bio-printed hair follicles and skin grafts to clinically test the products on human-like tissues. Additionally, various technological advancements, such as the development of organ-on-a-chip, are acting as other growth-inducing factors. These innovative bio-printed structures enable 3D in-vitro analysis of the bodily functions and fabrication of artificial organs and tissues for regenerative medicine and tissue engineering. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the increasing adoption of magnetic levitation technology for toxicity screening and vascular muscle printing, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, application and end user.

Breakup by Component:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others
       

Breakup by Application:

  • Research
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Others
       

Breakup by End User:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Component, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global 3D Bioprinting Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Component
    6.1    3D Bioprinters
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Syringe/Extrusion Bioprinting
           6.1.2.2 Inkjet Bioprinting
           6.1.2.3 Magnetic Levitation Bioprinting
           6.1.2.4 Laser-assisted Bioprinting
           6.1.2.5 Others
        6.1.3 Market Forecast
    6.2    Scaffolds
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Biomaterials
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Living Cells
           6.3.2.2 Hydrogels
           6.3.2.3 Extracellular Matrices
           6.3.2.4 Others
        6.3.3 Market Forecast
7   Market Breakup by Application
    7.1    Research
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Drug Research
           7.1.2.2 Regenerative Medicine
           7.1.2.3 3D Cell Culture
        7.1.3 Market Forecast
    7.2    Clinical
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Skin
           7.2.2.2 Bone and Cartilage
           7.2.2.3 Blood Vessels
           7.2.2.4 Others
        7.2.3 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research Organization and Academic Institutes
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Biopharmaceuticals Companies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    3D Systems Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Aspect Biosystems Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Cellink
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Cyfuse Biomedical K.K.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    EnvisionTEC GmbH (Desktop Metal Inc.)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Materialise
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Organovo Holdings Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Poietis
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    RegenHU
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Stratasys Ltd.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2021
Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2021
Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2021
Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2021
Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: 3D Bioprinting Market: Competitive Structure
Table 7: Global: 3D Bioprinting Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global 3D bioprinting market was valued at US$ 869 Million in 2021.

We expect the global 3D bioprinting market to exhibit a CAGR of 16.85% during 2022-2027.

The increasing application of 3D bioprinting for liver modeling and development of medical implants, is
currently catalyzing the global 3D bioprinting market.

The sudden outbreak of the COVID-19 pandemic has led to the rising use for 3D bioprinting as a rapid
fabrication method for designing and producing preventive, diagnostic, and treatment devices to
combat the spread of coronavirus infection.

Based on the component, the global 3D bioprinting market can be segmented into 3D bioprinters,
scaffolds, and biomaterials. Among these, 3D bioprinters, including syringe/extrusion bioprinting
currently holds the majority of the total market share.

Based on the application, the global 3D bioprinting market has been divided into research and clinical.
Currently, research exhibits a clear dominance in the market.

Based on the end user, the global 3D bioprinting market can be categorized into hospitals, research
organization and academic institutes, and biopharmaceuticals companies. Among these,
biopharmaceuticals companies currently account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global 3D bioprinting market include 3D Systems Inc., Aspect
Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM –
Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and
Stratasys Ltd.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links